• Organizer
  Roger Narayan
  UNC/NCSU Joint Department of Biomedical Engineering, USA
• Chair
  Roger Narayan
  UNC/NCSU Joint Department of Biomedical Engineering, USA
• Co-chair
  Jinah Jang
  Pohang University of Science and Technology, Korea, Republic of
• Speaker
  13:00~13:30
  Wei Sun
  Drexel University and Tsinghua University, China
  Presentation Title : Innovations in Bioprinting and Biofabrication Technologies

  Wei Sun
  (Drexel University and Tsinghua University, China)

  Dr. Sun Wei, a young researcher at State Key Laboratory for Modification of Chemical Fibers and Polymer Materials, College of Materials Science and Engineering, Donghua University. He obtained his Ph.D. from Tongji University in 2019 under the supervision of Professor Wu Guangming. He joined Donghua University in October 2019 and his main research areas include the design and construction of functional conductive elastic materials, and 3D printing of biomaterials for medical applications. He has published a total of 25 SCI papers, with 15 papers as the first author/corresponding author in international academic journals such as ACS Nano, Theranostics, J. Mater. Chem. A, Adv. Electron. Mater., etc. One of his papers has been highly cited according to ESI. He has filed 7 invention patents in China, 5 of which have been granted. He is the principal investigator for 1 National Natural Science Foundation of China (NSFC) Young Scientist Fund, 2 sub-projects of the Ministry of Science and Technology's key research and development program, and 1 collaborative project with industry.
• Speaker
  13:30~14:00
  James Yoo
  Wake Forest Institute for Regenerative Medicine, USA
  Presentation Title : Novel Materials for Regenerative Medicine
• Speaker
  14:00~14:30
  Jinah Jang
  Pohang University of Science and Technology, Korea, Republic of
  Presentation Title : Translational Studies Involving 3D Printing and Bioprinting Technologies
• Speaker
  14:30~15:00
  Roger Narayan
  UNC/NCSU Joint Department of Biomedical Engineering, USA
  Presentation Title : Innovations in Photopolymerization-based 3D Printing and Bioprinting Technologies
• Speaker
  15:00~15:30
  Jinye Wang
  Shanghai Jiao Tong University, China

  Jinye Wang
  (Shanghai Jiao Tong University, China)

  Prof. Jin-Ye Wang, Ph.D (Tohoku University, Japan, 1992). Professor of Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences (2000-2009); Professor of Biomedical Engineering, Shanghai Jiao Tong University (2009-). Published 140 papers and 6 books (chapters); authorized 20 patents; invited speaker of European Conference on Biomaterials, Pacifichem et al.; awarded Hundred Talent Program of the Chinese Academy of Sciences (1999), Life Sciences Prize from Meiji Dairies Corporation (2008) et al. Research interests: 3D Bioprinting, Tissue Engineering, Controlled Release, Biomimetic Materials and Biointerfaces. Selected Publications (2020-)： 1. Lin, Y.F., Yu, J.W., Zhang, Y.B., Hayat, H., Liu, C., Huang, X.Y., Lin, H.D.* and Wang, J.Y.* 4D Printed Tri-segment Nerve Conduit Using Zein Gel as the Ink for Repair of Rat Sciatic Nerve Large Defect. (2023) Biomaterial Advance, 151, 213473. 10.1016/j.bioadv.2023.213473 2. Hayat, H., Liu, C., Raza, A., Jingli Hou, J., Jia, C. and Wang, J.Y.* In vitro/in vivo identification of zein degraded peptides using HPLC-MS/MS and their safety evaluation. (2023) Biomedical Materials, 18, 025007. https://iopscience.iop.org/article/10.1088/1748-605X/acb411 3. Zhang,Y., Xue, Y., Ogawa, T., Wada, S. and Wang, J.Y.* 3D Printed Alginate Hydrogels with Stiffness-Gradient Structure in a Carbomer Supporting Bath by Controlled Ca2+ Diffusion. (2023) ACS Applied Engineering Materials, 1, 802-812. https://pubs.acs.org/doi/10.1021/acsaenm.2c00218 4. Jia, C.W., Zhang, Y.C., Wang, Y.Y., Gao, J.N., Raza, A., Ogawa, T., Wada, S., Xie, D. and Wang, J.Y.* Positively charged and neutral drug-loaded liposomes as the aerosolized formulations for the efficacy assessment of tumor metastases to lungs. (2023) Journal of Drug Delivery Science and Technology, 80, 104081. https://www.sciencedirect.com/science/article/pii/S1773224722009923 5. Zhang, Y.B., Raza, A., Xue, Y.Q., Yang, G.G., Hayat, U., Yu, J.W., Liu, C., Wang, H.J. and Wang, J.Y.* Water-responsive 4D printing based on self-assembly of hydrophobic protein “Zein” for the control of degradation rate and drug release. (2023) Bioactive Materials, 23, 343-352. 6. Raza, A., Zhang, Y.B., Uzma, H., Song, J.L., Shen, N.A., Chao, Y., Wang, H.J.* and Wang, J.Y.* Injectable zein gel with in situ self-assembly as hemostatic material. (2023) Biomaterial Advance, 145, 213225. 7. Xue, Y.Q., Zhang, Y.C., Zhang, Y.B. and Wang, J.Y.* Zein-based 3D Vascularized Scaffolds with Tunable Porosity for 3D Cell Culture and Drug Delivery. (2023) Biomedical Engineering Advances,5, 100059. https://www.sciencedirect.com/science/article/pii/S2667099222000354 8. Raza, A., Uzma, H., Zhang, X.H. and Wang, J.Y.* Self-assembled zein organogels as in situ forming implant drug delivery system and 3D printing ink. (2022) International Journal of Pharmaceutics, 627, 122206. 9. Li, J., Zhou, Y., Xu, J., Gao, F., Si, Q., Wang, J.Y., Zhang, F. and Wang, L.P.* Water-Soluble and Degradable Gelatin/Polyaniline Assemblies with High Photothermal Conversion Efficiency for pH Switchable Precise Photothermal Therapy. （2022）ACS Applied Materials & Interfaces, 14, 52670-52683. 10. Liu, C., Uzma, H., Raza, A., Jia, C.W. and Wang, J.Y.* Zein-based injectable biomaterial and angiogenic activity through peptides produced by enzymatic degradation. (2022) Journal of Drug Delivery Science and Technology, 78, 103937. 11. Zhang, Y.B., Wang, H.J., Raza, A., Liu, C., Yu, J.W. and and Wang, J.Y.* Preparation and evaluation of chitosan/polyvinylpyrrolidone/zein composite hemostatic sponges. (2022) International Journal of Biological Macromolecules. 205, 110-117. 12. Uzma, H., Raza, A., Bilal, M.N. lqbal, H.M.N* and Wang, J.Y.* Biodegradable polymeric conduits: Platform materials for guided nerve regeneration and vascular tissue engineering. (2022) Journal of Drug Delivery Science and Technology, 67, 103014. 13. Liu, C., Yang, H., Shen, N.A., Li, J.H., Chen, Y.S. and Wang, J.Y.* Improvement of Mechanical Properties of Zein Porous Scaffold by Quenching/Electrospun Fiber Reinforcement. (2021) Biomedical Materials, 16, 065016. 14. Wang, H.J.*, Mao, Q.Y., Feng, G., Liu, C., Yang, M.Z., Hao, M.F., Meng, Z.F., Li, S.M., Zhang, Y.P. and Wang, J.Y.* 3D printing of multi-functional artificial conduits against acute thrombosis and clinical infection. (2022) Composites Part B-Engineering, 230, 109497. 15. Yu, J.W., Wang, G.W., Lin, Y.F., Song, J.L., Hayat, U., Liu, C., Raza, A., Wu, W.F., Lin, H.D. and Wang, J.Y.* Zein-induced immune response and modulation by size, pore structure and drug-loading: Application for sciatic nerve regeneration. (2022) Acta Biomaterialia, 140, 289-301. 16. Wang, L.P., Wang, H.J., Hou, X.S., Raza A. and Wang, J.Y.* Preparation of stretchable composite film and its application in skin burn repair. (2021) Journal of the Mechanical Behavior of Biomedical Materials, 113, 104114. 17. Shen, N.A., Zhang, Y. and Wang, J.Y.* A parallel plate flow chamber device for evaluation of cell retention of electrospun zein fiber film under steady shear. (2021) Journal of Shanghai Jiaotong University (Sci), 26 (1), 69-75. 18. Shen, N.A., Zhang, Y. and Wang, J.Y.* Effects of the micro/nanostructure of electrospun zein fibres on cells in a fluid environment. (2021) Materials Science and Engineering C, 122, 111900. 19. Hou X.S., Zhou Y., Liu Y.J., Wang L.P.*, Wang J.Y. Coaxial electrospun flexible PANI//PU fibers as highly sensitive pH wearable sensor. (2020) Journal of Material Science, 55(33), 16033-16047. 20. Raza, A., Uzma, H., Bilal, M., lqbal, H.M.N* and Wang, J.Y.* Zein-based micro- and nano- constructs and biologically therapeutic cues with multi-functionalities for oral drug delivery systems. (2020) Journal of Drug Delivery Science and Technology, 58, 101818. 21. Uzma, H, Raza, A. and Wang, J.Y.* Preparation of Zein/PVP based conduits with tunable degradation. (2020) Polymer Degradation and Stability, 181, 109303. 22. Raza, A., Uzma, H., Wang, H.J. and Wang, J.Y.* Preparation and evaluation of captopril loaded gastro-retentive zein based porous floating tablets. (2020) International Journal of Pharmaceutics, 579, 119185. 23. Uzma, H., Raza, A., Wang, H.J.* and Wang, J.Y.* Preparation of ciprofloxacin loaded zein conduits with good mechanical properties and antibacterial activity. (2020) Materials Science and Engineering C, 111, 110766.

Industrial and academic researchers have recently examined the use of 3D printing and bioprinting technologies to overcome the limitations associated with conventional biomedical manufacturing processes. These technologies involve the processing of biomaterials into three-dimensional structures through the joining of materials in a layer-by-layer manner. This workshop will review recent developments in 3D printing and bioprinting technologies for processing biomaterials into artificial tissues as well as biosensors, drug delivery devices, and medical instruments. Several topics related to 3D printing and bioprinting, including the development of appropriate computer models, novel 3D printing and bioprinting technologies, and novel materials for use in 3D printing and bioprinting, will be discussed. This workshop will create collaboration among the many groups involved in the development and use of 3D printing and bioprinting technologies, including biomaterials scientists, medical device manufacturers, and clinicians. We anticipate that this workshop will facilitate future research activities, including industry-university collaborations, involving 3D printing and bioprinting of biomaterials for use in medicine, surgery, and dentistry. 
The target audience will include: 
- university-, government-, and industry-based biomaterial engineers
- medical scientists
- medical device manufacturers
- equipment manufacturers
- regulatory officials and administrators
- clinicians

• Organizer
  Bingyun Li
  West Virginia University School of Medicine, USA
• Chair
  Jian Yang
  Westlake University, China

  Jian Yang
  (Westlake University, China)

  Dr. Jian Yang is currently a Chair Professor in Biomaterials and Regenerative Engineering, the chair of Biomedical Engineering Program, and an Associate Vice President at the Westlake University. Prior to Westlake, he was a Professor of Biomedical Engineering and Dorothy Foehr Huck and J. Lloyd Huck Chair in Regenerative Engineering at the Pennsylvania State University. Dr. Yang is known for his pioneering contribution on citrate chemistry and biology for the development and applications of citrate-based biomaterials. He was a recipient of NSF CAREER Award (2010), Outstanding Young Engineering Faculty Award at UTA (2011), PSEAS Outstanding Research Award at Penn State (2018), and BMES Wallace H. Coulter Award for Healthcare Innovation Award (2023). Dr. Yang is an elected Fellow of American Institute of Medical and Biological Engineering (AIMBE, 2016), the National Academy of Inventors (NAI, 2018), the Biomedical Engineering Society (BMES, 2020), the American Association for the Advancement of Science (AAAS, 2021), and the International Academy of Medical and Biological Engineering (IAMBE, 2023). Dr. Yang is the Co-Editor-in-Chief of “Bioactive Materials”, and an Associate Editor of “Science Advances”. Dr. Yang is a co-founder and the Past-President of Chinese Association for Biomaterials (CAB) and the recipient of 2023 CAB Distinguished Leadership and Service Award. Dr. Yang co-founded a medical device company, Aleo BME, Inc. and is also serving on the Scientific Advisory Board of Acuitive Technologies, LLC.
• Co-chair
  Kelvin Yeung
  The University of Hong Kong, Hong Kong SAR, China
• Speaker
  16:00~16:35
  William Wagner
  University of Pittsburgh, USA
  Presentation Title : Developing biomaterials and scaffolds to meet distinct clinical needs
• Speaker
  16:35~17:10
  Guillermo Ameer
  Northwestern University, USA
  Presentation Title : Regenerative Biomaterials and medical devices: A new hope
• Speaker
  17:10~17:45
  Xuesi Chen
  University of Chinese Academy of Sciences, China
  Presentation Title : Biodegrade polymers and their biomedical applications
• Speaker
  17:45~18:20
  Shaoyi Jiang
  Cornell University, USA
  Presentation Title : Biomaterials beyond poly(ethylene glycol)

  Shaoyi Jiang
  (Cornell University, USA)

  Shaoyi Jiang joined the Meinig School of Biomedical Engineering at Cornell as the Robert Langer ’70 Family and Friends Professor in June 2020. Before Cornell, he was the Boeing-Roundhill Professor of Engineering in the Department of Chemical Engineering and an adjunct professor of Bioengineering at the University of Washington, Seattle. He received his Ph.D. degree in chemical engineering from Cornell University in 1993. He was a postdoctoral fellow at the University of California, Berkeley between 1993 and 1994 and a research fellow at California Institute of Technology between 1994 and 1996 both in chemistry. He is currently a fellow of the American Association for the Advancement of Science (AAAS), a fellow of the American Institute of Chemical Engineers (AIChE), a fellow of the American Institute for Medical and Biological Engineering (AIMBE), an executive editor for Langmuir and an associate editor for Science Advances. He received the Braskem Award for Excellence in Materials Engineering and Science, AIChE (2017). His research focuses on biomaterials, particularly highly biocompatible and environmentally benign zwitterionic-based materials for biomedical and engineering applications.

Innovative biomaterial research and development have greatly improved the health and economy worldwide. The objective of this workshop is to host the biomaterial leaders to discuss the key elements en route to successful biomaterial technology translation with the participation of academic researchers, investors, industrial leaders, scientists, and students. The outcome is to a platform where biomaterial excellence finds its exit to technology translation and a networking opportunity to mingle with academic and industrial leaders in biomaterials. This workshop is relevant to the WBC topics including Biomaterials for industrial applications, Biomaterials enabling technologies, Biomaterials for pre-clinical and clinical translation, and Biomaterials for tissue engineering.

• Organizer
  Xing-Jie Liang
  National Center for Nanoscience and Technology of China, China
  Xing-Jie Liang
  (National Center for Nanoscience and Technology of China, China)

  Xing-Jie LIANG, Ph.D.
  Member of Academia Europaea
  Fellow of American Institute of Medical and Biological Engineering
  Chief Professor, University of Chinese Academy of Sciences
  CAS Center for Excellence in Nanoscience
  CAS Key Lab of Bioeffects of Nanomaterials and Nanosafety
  National Center for Nanoscience and Technology of China
  E-mail： liangxj@nanoctr.cn
  Tel: +86-010-82545569 Fax: +86-010-62656765
  ORCID: 0000-0002-4793-1705
  
  
  Dr. Xing-Jie Liang got Ph.D at National Key Laboratory of Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences. He finished his postdoc with Dr. Michael M. Gottesman, member of NAS and Deputy Director of NIH, for 5 years at Laboratory of Cell Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health. Then, he worked as a Research Fellow at Surgical Neurology Branch, NINDS, NIH. Dr. Liang currently is a principal investigator at Center for Excellence in Nanoscience, Chinese Academy of Sciences. He as previous president of Chinese Association of Nanobiology is the Member of Academia Europaea (2023) and the elected Fellow of American Institute for Medical and Biological Engineering (AIMBE, 2020) and Faculty Member of F1000 Research (Pharmacology & Drug Delivery, 2012) and Hall of Fame (Advanced Materials, 2023). Dr. Liang has successfully developed “Injectable Nanomicelle Powder with Irinotecan” approved with CFDA and transferred NDA to pharmaceutical industry for clinical trials.
  
  His group has published over 300 peer-reviewed articles, H-index > 100. His research interests are in elucidating mechanisms to improve drugability and nanomedicinal bioavailability by nanotechnology in vitro and in vivo, and novel strategies to increase therapeutic efficiency on cancers and infective diseases. Developing drug delivery strategies for prevention/circumvent of clinical adaptive treatment tolerance (ATT) are current programs ongoing in Professor Liang's lab based on understanding of basic physio-chemical and biological processes of nanomedicine.
• Chair
  Xing-Jie Liang
  National Center for Nanoscience and Technology of China, China

  Xing-Jie Liang
  (National Center for Nanoscience and Technology of China, China)

  Xing-Jie LIANG, Ph.D. Member of Academia Europaea Fellow of American Institute of Medical and Biological Engineering Chief Professor, University of Chinese Academy of Sciences CAS Center for Excellence in Nanoscience CAS Key Lab of Bioeffects of Nanomaterials and Nanosafety National Center for Nanoscience and Technology of China E-mail： liangxj@nanoctr.cn Tel: +86-010-82545569 Fax: +86-010-62656765 ORCID: 0000-0002-4793-1705 Dr. Xing-Jie Liang got Ph.D at National Key Laboratory of Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences. He finished his postdoc with Dr. Michael M. Gottesman, member of NAS and Deputy Director of NIH, for 5 years at Laboratory of Cell Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health. Then, he worked as a Research Fellow at Surgical Neurology Branch, NINDS, NIH. Dr. Liang currently is a principal investigator at Center for Excellence in Nanoscience, Chinese Academy of Sciences. He as previous president of Chinese Association of Nanobiology is the Member of Academia Europaea (2023) and the elected Fellow of American Institute for Medical and Biological Engineering (AIMBE, 2020) and Faculty Member of F1000 Research (Pharmacology & Drug Delivery, 2012) and Hall of Fame (Advanced Materials, 2023). Dr. Liang has successfully developed “Injectable Nanomicelle Powder with Irinotecan” approved with CFDA and transferred NDA to pharmaceutical industry for clinical trials. His group has published over 300 peer-reviewed articles, H-index > 100. His research interests are in elucidating mechanisms to improve drugability and nanomedicinal bioavailability by nanotechnology in vitro and in vivo, and novel strategies to increase therapeutic efficiency on cancers and infective diseases. Developing drug delivery strategies for prevention/circumvent of clinical adaptive treatment tolerance (ATT) are current programs ongoing in Professor Liang's lab based on understanding of basic physio-chemical and biological processes of nanomedicine.
• Co-chair
  Bingyang Shi
  Henan University, China
• Speaker
  16:30~17:00
  Kam Leong
  Columbia University, USA
  Presentation Title : Immunological modulation of Biomaterials
• Speaker
  17:00~17:20
  Daxiang Cui
  Henan University, China
• Speaker
  17:20~17:40
  Juyong Yoon
  Ewha Womans University, Korea, Republic of

  Juyong Yoon
  (Ewha Womans University, Korea, Republic of)

  Juyoung Yoon is a distinguished professor at the Department of Chemistry and Nanoscience, Ewha Womans University. He received his PhD (1994) from Ohio State University and conducted his postdoctoral work at UCLA and Scripps Research Institute. His research interests include investigations of fluorescent imaging probes, activatable photosensitizers, phototherapy and organic functional materials. His h-index is 124 and was listed as a highly cited researcher in chemistry for 2014-2023.
• Speaker
  17:40~18:00
  Guixue Wang
  Bioengineering College of Chongqing University, China

  Guixue Wang
  (Bioengineering College of Chongqing University, China)

  Dr. Guixue Wang is a Distinguished Professor of Biomedical Engineering and former Dean of the College of Bioengineering, Chongqing University, China. He also worked as the Principal Investigator of JinFeng Laboratory at Chongqing. He has also served as a Deputy Director of the Academic Committee of Chongqing University Health Science Center. He is a director of the Key Laboratory of Biorheology Science and Technology of the Chinese Ministry of Education, a founding director of the Public Experiment Center of National Biological Industrialization Base at Chongqing, and a founding director of the National Local Joint Engineering Laboratory for Vascular Implants of China, a founding director of Chongqing Engineering Laboratory for Vascular Implants of China. He serves as an Associate Editor of Research (IF:11), Deputy Editor-in-Chief of Molecular & Cellular Biomechanics, an Associate Editor of Journal of Medical and Biological Engineering, and an Editorial Member of Biomedical Materials. He also serves as a reviewer for 50 international journals. He has served as multiple Chairpersons: including Branch of Atherosclerosis of the Chinese Society of Pathophysiology (2021.05-) and Materiobiomechanics Branch of the Chinese Society for Biomaterials (2022.12-), Honorary Chairperson: Vascular Branch of the Chinese Society of Anatomy (2023.12-), Executive Member of the Council: Interventional Treatment of Cardiac and Brain Diseases Branch of the Chinese Medical Device Industry Association (2017-), Cardiovascular Biomaterials Branch of the Chinese Society for Biomaterials (2015-), Chinese Branch of International Society of Atherosclerosis (2015-), Holistic Integrative Medicine and Engineering Alliance (2018-); Member of the Council: Chinese Society of Biomedical Engineering (2015-1019), Chinese Society for Biomaterials (2012-), Biomechanics Branch of the Chinese Society of Mechanics/Chinese Society of Biomedical Engineering (2015-), and Life Member: including World Association for Chinese Biomedical Engineers (2016-) and International Chinese Musculoskeletal Research Society (2019-). His areas of research interest include vascular biomechanics and mechanobiology, tissue repair materials and minimally invasive interventional medical devices. He has led more than 20 national and provincial-level key scientific research projects; collaboratively published more than 300 SCI/EI indexed papers in Nat Neurosci, J Biomech, Adv Sci, Bioact Mater, Biomaterials and other academic journals; authorized more than 60 domestic and international patents; and won 6 provincial and ministerial science and technology and teaching achievement awards, 3 national industry associations and societies awards. He was selected as the Elsevier “Most Cited Chinese Researchers in Biomedical Engineering” in 2019, 2020, 2021, 2022 and 2023; World's Top 2% Scientists in 2023; and a Fellow of International Union of Societies for Biomaterials Science and Engineering (FBSE) in 2023.
• Speaker
  18:00~18:20
  Hyung-Jun Im
  Seoul National University, Korea, Republic of
• Speaker
  18:20~18:40
  Dong Ma
  Jinan University, China

Objectives or purposes
Explore a better future with advanced science and technology
Proposed program and target audience
Include at least 4-5 wellknown scientists in the biomateials field, they have very excellent reputation and scientific credits internationally on the immunological regulation of biomaterials applied in clinic as scarfold. The targeted audiences are suitable for undergraduates or graduates and earlier careers of pricinpal investigators who are interested in the multiple functions of biocompatible materials applied in vivo for replacement of tissue or efficient treatment of maglinent tumors.
Expected outcomes and relevance to the main topic of WBC 2024
Wish this workshop as platform to attract more students and young scientists who are involved in the biomaterials practical transition for clinical applications, the audences will receive broader overview on the immunoligical outcome of Biomaterials how it works efficiently in vivo by a novel pathway. It will construct straight bridge to tight with main topic of WBC 2024 and broader the coverage of conference with additional mechanism and scientific direction of biomaterials.